DrugPatentWatch

Competitive intelligence on small-molecule drugs and the 80,000 patents covering them

Simple flat-rate subscription plans

Ultimate Plan

$495/ month or  $2,495/ year

Generic Name: pregabalin

Summary for Generic Name: pregabalin

Tradenames:2
Patents:4
Applicants:4
NDAs:6
Drug Master File Entries: see list24
Suppliers: see list5
Therapeutic Class:Anticonvulsants
Formulation / Manufacturing:see details

Tentative approvals for PREGABALIN

Applicant Application No. Form Dosage
<disabled><disabled>CAPSULE; ORAL150MG
<disabled><disabled>CAPSULE; ORAL200MG
<disabled><disabled>CAPSULE; ORAL25MG

Clinical Trials for: pregabalin

A Randomized Double-Blind Study Testing the Effects of Pregabalin on Diabetic Neuropathy
Status: Completed Condition: Diabetic Neuropathy

Chronic Pain Management After Herniorraphy
Status: Completed Condition: Chronic Pain

Pregabalin and Orofacial Neuropathic Pain
Status: Terminated Condition: Neuralgia; Orofacial Pain

Role of Pregabalin in Treatment of Post-Op Pain in Fracture Patients
Status: Completed Condition: Post-operative Pain

Efficacy And Safety Study Of Pregabalin (Lyrica) As Monotherapy In Patients With Partial Seizures
Status: Terminated Condition: Epilepsies, Partial

Pregabalin on Interleukin-6 Levels in Living Donor Kidney
Status: Completed Condition: Pain

Courtesy of ClinicalTrials.org
See more clinical trials for this drug

Glossary
Applicant Tradename Generic Name Dosage NDA Approval Date Type RLD Patent No. Patent Expiration Product Substance Delist Req. Patented / Exclusive Use
Pf Prism
LYRICA
pregabalin
CAPSULE;ORAL021446Dec 30, 2004RXNo5,563,175<disabled>TREATMENT OF SEIZURE DISORDER
Pf Prism
LYRICA
pregabalin
CAPSULE;ORAL021446Dec 30, 2004RXNo6,001,876<disabled>YMANAGEMENT OF FIBROMYALGIA
Pf Prism
LYRICA
pregabalin
CAPSULE;ORAL021446Dec 30, 2004RXNo6,001,876<disabled>YTREATMENT OF PAIN
Pf Prism
LYRICA
pregabalin
CAPSULE;ORAL021446Dec 30, 2004RXNoRE41920<disabled>TREATMENT OF PAIN, INCLUDING NEUROPATHIC PAIN ASSOCIATED WITH DIABETIC PERIPHERAL NEUROPATHY OR SPINAL CORD INJURY, POSTHERPETIC NEURALGIA, AND FIBROMYALGIA
This preview shows a limited data set
Complete access is available with a Subscription
first patents previous patents next patents last patents

Export unavailable in trial.
Subscribe for complete access.

« Back to Dashboard

DrugPatentWatch Archives

You are viewing the current data set
Select a link below to view the archives:

 2000  2001  2002  2003  2004  2005  2006  2007  2008  2009 
 2010  2011  2012  2013 

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors.

Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided information. There is no warranty that the information contained herein is error free. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Connect with Social Media:

Follow DrugPatentWatch on Twitter Connect with DrugPatentWatch on Linkedin Drug Patents on LinkedIn

Copyright © 2002-2014 thinkBiotech LLC. ISSN: 2162-2639

Other thinkBiotech sites: BiotechUBiotechBlogJournal of Commercial Biotechnology

`abc